Elizabeth Faust

Director/Board Member at BIOMEA FUSION, INC.

Net worth: - $ as of 31/05/2026

61 year

Health Technology

Consumer Services

Profile

Elizabeth A. Faust is currently Independent Director at Biomea Fusion, Inc. since 2022 and Principal & Owner at Faust Consulting LLC since 2018.
Former roles include Executive Director-Regional Medical Liaisons at Amgen, Inc., Senior Director-Medical Affairs at Gloucester Pharmaceuticals, Inc. from 2008 to 2010, Vice President-Medical Affairs at Pharmacyclics LLC from 2013 to 2015, Executive Vice President-Medical Affairs at Tricida, Inc. from 2019 to 2020, Vice President-Clinical Research Sciences at Celgene Corp., Vice President-Medical Affairs at Kite Pharma, Inc. from 2016 to 2018, and Vice President-Medical Affairs at Pharmacyclics, Inc. from 2013 to 2015.
Education includes a doctorate from the University of California, Los Angeles, graduate studies at the University of California, Riverside, and undergraduate studies at Auburn University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BIOMEA FUSION INC -.--%	10/06/2026	0 ( -.--% )	- $	31/05/2026

Elizabeth Faust active positions

Companies	Position	Start
BIOMEA FUSION, INC.	Director/Board Member	01/06/2022

All active positions of Elizabeth Faust

Former positions of Elizabeth Faust

Companies	Position	End
TRICIDA, INC.	Chief Tech/Sci/R&D Officer	01/08/2020
CELGENE	Chief Tech/Sci/R&D Officer	01/11/2019
KITE PHARMA INC	Chief Tech/Sci/R&D Officer	01/07/2018
PHARMACYCLICS, INC.	Chief Tech/Sci/R&D Officer	01/11/2015
Pharmacyclics, Inc. Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer	Chief Tech/Sci/R&D Officer	01/11/2015

See the detail of Elizabeth Faust's experience

Training of Elizabeth Faust

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Elizabeth Faust's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs	Health Technology
Pharmacyclics LLC Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis	Health Technology
Gloucester Pharmaceuticals, Inc. Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients	Health Technology
Tricida, Inc. Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products	Health Technology
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Auburn University Auburn University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Riverside University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kite Pharma, Inc. Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products	Health Technology
Biomea Fusion, Inc. Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers	Health Technology
Pharmacyclics, Inc. Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer	Health Technology